Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil.
Paulo Lisboa BittencourtPaulo Lisboa BittencourtAlessandra Maria Dias Guimarães CésarFernanda Carneiro MussiMaria Lúcia Gomes FerrazPublished in: Telemedicine journal and e-health : the official journal of the American Telemedicine Association (2023)
Introduction: To accomplish elimination of hepatitis C virus (HCV) by 2030, as proposed by the World Health Organization, the Brazilian Ministry of Health outlined the Hepatitis C Elimination Plan, which provides coverage of all critical steps in the continuum of care (CoC) of hepatitis C. As expected, the advent of COVID-19 pandemic has disrupted the CoC of hepatitis C worldwide. The Brazilian Liver Institute launched a remote patient monitoring (RPM) program to assist the general population at risk in HCV testing and to provide linkage and retention to care for HCV-positive subjects. The RPM program was also designed to relink HCV-positive patients lost to follow-up during the COVID-19 pandemic due to their limited access to the health care system. Methods: The HCV telemonitoring number was highly advertised in Brazilian media. The RPM program was conducted by dedicated health care personnel trained to follow a predefined script designed to provide awareness, ensure consistent information for educational purposes, and recruit eligible participants to be tested for HCV. Results: From August 2020 to December 2021, 3,738 subjects entered in contact with RPM. There were 26,884 interactions (mean 7.2 interactions per participant), mostly by WhatsApp (78%). Twenty out of those 221 subjects (9%) who tested were HCV positive. Those subjects altogether with 128 other patients with HCV, tested elsewhere, were followed in the HCV CoC. Up to now, 94% of them were linked to care, 24% are undergoing treatment and 8% achieved sustained virological response (SVR). Conclusions: Our preliminary results showed that HCV CoC telemonitoring was a feasible and useful strategy to follow HCV at-risk subjects through all cascade of care until SVR during the COVID-19 health care disruption. It could be used beyond the defervescence of SARS-CoV-2 pandemic to ensure linkage to care of those HCV-positive patients.
Keyphrases
- hepatitis c virus
- healthcare
- human immunodeficiency virus
- quality improvement
- sars cov
- palliative care
- coronavirus disease
- ejection fraction
- end stage renal disease
- pain management
- newly diagnosed
- prognostic factors
- men who have sex with men
- chronic pain
- hiv testing
- health information
- hiv infected
- social media
- genome wide
- patient reported
- respiratory syndrome coronavirus